Published Sat, 26 Oct 2019 07:04:52 -0400 on Seeking Alpha
October has been a very busy month on the dividend stock purchases front for me. The "Free Stock Trade" wars allowed me to reduce my cost per transaction to $0, which unlocked the ability to purchase stocks in small quantities. With cash sitting in my brokerage account, I was ready to take advantage of companies that passed the metrics of our Dividend Stock Screener.
At the end of the month, I will update my Dividend Stock portfolio on our website. So you will be able to see the full impact of the transactions on my overall portfolio and my forward dividend income. The name of the game is financial freedom, so I am going to be more aggressive putting my capital to work, pushing forward my dividend income, and growing that number as much as possible.
Let's see the companies that were purchased and the impact each had on my forward dividend income. For each of the companies, at the time of the purchase, I ran the companies through our Dividend Stock Screener. The results of the stock screener are below, using the purchase price, average analyst earnings per Yahoo! Finance, and the company's dividend growth rate per dividendinvestor.com.
AbbVie, Inc. (NYSE: ABBV)
On 10/2/19, I purchased six shares of AbbVie, Inc. In 2018, I initiated a position in the company. Despite the fact that I missed the buying opportunity after the announcement of its pending acquisition of Allergan, I decided to add to my position at the beginning of the month due to the metrics. ABBV is still... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
|CANADIAN IMPERIAL BANK OF COMMERCE||81.35||9.5||8.59||4.33||5.17|
|DELTA AIR LINES||59.44||8.9||6.70||1.61||2.75|
Older articles featuring Abbvie (ABBV):27 Durable Dividend Dogs For Our Times: The May Uprising
Health Care Select Sector SPDR ETF: Consistent Dividend Growth And Better Growth Profile Than The S&P 500
HIE: Near 4% Annual Alpha From This High Dividend Equity Closed-End Term Fund
My Dividend Growth Portfolio April Update: 41 Holdings, 0 Buys, 10 Sells
Dividend Challenger Highlights: Week Of May 10
Coronavirus Roundtable - Quality Pays For Dividend Investors (Video)
5%+ Dividend Yield Portfolio: Bracing For The Retest (April 2020 Review)
Looking For Double-Digit Dividend Growth In Today's Uncertain Times
The 13 Best Dividend Aristocrats To Buy In This Uncertain Economy
Dividend Challenger Highlights: Week Of April 12